Author:
Mahtani Kamal R,Heneghan Carl J,Tai Tracy W
Reference34 articles.
1. Agarwal A York M Kantharia BK Ezekowitz M Atrial fibrillation: Modern concepts and management Annual Review of Medicine 2005 475 94
2. Oral anticoagulants versus antiplatelet therapy for preventing stroke in patients with non-valvular atrial fibrillation and no history of stroke or transient ischemic attacks;Aguilar Maria;Cochrane Database of Systematic Reviews,2007
3. Albers GW Diener H-C Frison L Grind M Nevinson M Partridge S Ximelagatran vs warfarin for stroke prevention in patients with nonvalvular atrial fibrillation: a randomized trial JAMA 2005 690 8
4. Amadeus I Bousser MG Bouthier J Buller HR Cohen AT Crijns H Comparison of idraparinux with vitamin K antagonists for prevention of thromboembolism in patients with atrial fibrillation: a randomised, open-label, non-inferiority trial.[Erratum appears in Lancet. 2008 Dec 13;372(9655):2022. Note: Thorp-Pedersen, C [corrected to Torp-Pedersen, C]] Lancet 2008 315 21
5. Astellas Pharma I Direct factor Xa inhibitor YM150 for prevention of stroke in subjects with non-valvular atrial fibrillation ClinicalTrials.gov 2007
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献